The effect of oestrogen on cytokine and antioxidant levels in male to female transsexual patients

Maturitas

Volumn 55, Issue 1, 2006, Pages 14-18

  Wilson, Rhoda ^a   Jenkins, Carol ^a   Miller, Helen ^a   Carr, Susan ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b Sandyford Initiative   (United Kingdom)

Author keywords

Antioxidants; Cytokines; Oestrogen; Transsexual patients

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; CYTOKINE; ESTROGEN; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; NITRIC OXIDE; PREMARVIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME BLOOD LEVEL; FEMALE; HUMAN; IMMUNE SYSTEM; LIPID BLOOD LEVEL; LONG TERM CARE; MALE; STATISTICAL SIGNIFICANCE; TRANSSEXUALISM; TRIACYLGLYCEROL BLOOD LEVEL;

ANTIOXIDANTS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CYTOKINES; ESTROGENS; GLUTATHIONE; HUMANS; INTERLEUKIN-6; MALE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TRANSSEXUALISM; TRIGLYCERIDES;

EID: 33746257299     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.01.001     Document Type: Article

References (22)

1. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., and Hennekers C.H. Menopause and the risk of coronary heart disease in women. New Eng J Med 316 (1987) 1105-1110
2. Castelli W.P. Epidemiology of coronary heart disease: the Framingham Study. Am J Med 76 (1984) 4-12
3. Hulley S.B., and Grady D. The WHI Estrogen alone trial-do things look any better?. J Am Med Assoc 219 (2004) 1769-1771
4. Subbiah MT.R. Estrogen replacement therapy and cardio protection: mechanisms and controversies. Braz J Med Biol Res 35 (2002) 271-276
5. Walsh B.W., Sciff I., Rosner B., Greenberg L., Ravnikar V., and Sacks F.M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. New Eng J Med 325 (1991) 1196-1206
6. Gruchow H.W., Anderson A.J., Barboriak J.J., and Sobocinski K.A. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 11 (1988) 954-963
7. Rosselli M., Imthurn B., Macas E., Keller P.J., and Dubey R.K. Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for estradiol mediated NO release. Biochem Biophys Res Commun 202 (1994) 1543-1545
8. Cicinelli E., Ignarro L.J., Schonauer L.M., Matteo G., Galantino P., and Balzano G. Effects of short-term transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil Steril 67 (1998) 58-61
9. Ayers S., Abpianalp W., Liu J.H., and Subbiah MT.R. Mechanisms involved in the protective effects of oestradiol_17β on lipid peroxidation and DNA damage. Am J Physiol 274 (1998) 1002-1008
10. Davidson S., and Davis S.R. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 88 (2003) 2470-2478
11. Van Kesteren P., Lips P., Gooren L.J., Asscheman H., and Megens J. Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol 48 (1998) 347-354
12. Toorians A.W.F.T., Thomassen M.C.L.G.D., Zweegman S., et al. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 88 (2003) 5723-5729
13. Miller H., Wilson R., Jenkins C., Roberts J., and Walker J.J. Glutathione influences the TH1/TH2 response. Fertil Steril (2000) 74
14. Lipid research clinics programme. Manual of laboratory operations, vol. 1. Lipid and lipoprotein analysis. Bethesda, MD: National Institute of Health DHEW Publications (NIH); 1971. p. 75.
15. McCrohon J.A., Walters W.A.W., Robinson J.T.C., et al. Arterial re-activity is enhanced in genetic males taking high dose estrogens. J Am Coll Cardiol 29 (1997) 1432-1436
16. New G., Timmins K.L., Duffy S.J., et al. Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol 29 (1997) 1437-1444
17. Damewood M.D., Bellantoni J.J., Bachorik, et al. Exogenous estrogen effects on lipids/lipoprotein cholesterol in transsexual males. J Endocrinol Invest 12 (1989) 449-45418
18. Ozden S., Dildar K., Kadir Y.H., and Gulizar K. The effects of hormone replacement therapy on lipid peroxidation and antioxidant status. Maturitas 38 (2001) 165-170
19. Akcay T., Dincer Y., Kayali R., Colgar U., Oral E., and Cakatay U. Effects of hormone replacement therapy on lipid peroxides and oxidation system in postmenopausal women. J Toxicol Environ Health 59 (2000) 1-5
20. Valenti S., Fazzuoli L., and Giusti M. Circulating nitric oxide levels increase after anti-androgen treatment in male-to-female transsexuals. J Endocrinol Invest 26 (2003) 522-526
21. Rachon D., Mysliwska J., Suchecka-Rachon K., Wieckiewicz J., and Mylsliwski. A Effects of oestrogen deprivation on interleukin 6 production by peripheral blood mononuclear cells of postmenopausal women. J Endocrinol 172 (2002) 387-395
22. Davidson S., and Davis S.R. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Enodrinol Metab 88 (2003) 2470-2478